We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Perrigo announced that Sun Pharmaceutical and MiCal Pharmaceuticals initiated patent litigations on May 9 and 10, 2018, in the U.S. District Court for the District of Delaware